Klick Health gath­ers biotech and phar­ma lu­mi­nar­ies to dis­cuss in­dus­try in­no­va­tions, in­vest­ments and fu­ture

At Klick Health’s first Ideas Ex­change con­fer­ence with biotech and phar­ma in­dus­try in­sid­ers since be­fore the pan­dem­ic be­gan, it was no sur­prise many con­ver­sa­tions in­clud­ed Covid top­ics. Yet while vac­cines and treat­ments were dis­cussed, so too were the ef­fects on drug de­vel­op­ment, fed­er­al re­spons­es, health in­equities — and what to do now and next.

George Yan­copou­los, chief sci­en­tist and co­founder of Re­gen­eron, opened the con­fer­ence re­spond­ing to a ques­tion from Acor­da CEO Ron Co­hen about the spot­light on the in­dus­try dur­ing Covid and some of the “flak” bio­phar­ma has tak­en in the past.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER